Atlas FDA

LEGOO ENDOVASCULAR OCCLUDER

FDA premarket approval P110003/S001 · decided 2012-03-01

Approval details

PMA number
P110003
Supplement
S001
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LEGOO ENDOVASCULAR OCCLUDER
Generic name
Occluder, internal vessel, temporary
Applicant
Genzyme Corp.
Date received
2011-11-15
Decision date
2012-03-01
Days to decision
107 days
Decision code
APPR
Product code
OBC
Advisory committee
Cardiovascular
Expedited review
No
Location
Cambridge, MA
Statement
APPROVAL FOR A CHANGE TO A STERILIZATION PROCESS PARAMETER.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OSOM INFLUENZA A&B TEST (K061508)Genzyme Corp.2006-06-12
GENZYME OSOM INFLUENZA A & B TEST (K051244)Genzyme Corp.2006-02-21
N-GENEOUS WIDE RANGE CRP REAGENT AND CALIBRATOR SET (K040241)Genzyme Corp.2004-06-25
SEPRAMESH IP BIORESORBABLE BARRIER - PERMANENT MESH (K040868)Genzyme Corp.2004-06-04
GENZYME OSOM TRICHOMONAS RAPID TEST (K033864)Genzyme Corp.2004-04-02
GENZYME CONTRAST II HCG URINE/SERUM TEST (K023544)Genzyme Corp.2003-01-16
ULTRA N-GENEOUS HDL CHOLESTEROL REAGENT 1/REAGENT2; ULTRA N-GENEOUS HDL CHOLESTREOL CALIBRATOR (K021316)Genzyme Corp.2002-07-25
COTTONY II, SILKY II POLYDEK & TEVDEK II POLYESTER SUTURE (K021019)Genzyme Corp.2002-06-18